Skip to main content
OpenTrials

Clinical trial condition

Ovarian Neoplasms

Explore clinical trials studying Ovarian Neoplasms. Study availability and eligibility vary by location and protocol.

2,333 public trials 507 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Neoplasms trial results

Recruiting

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

NCT07229313

Conditions
Adnexal Diseases, Advance Solid Tumors, Breast Diseases, +59 more
Locations
  • Kivu Trial Site Santa Monica, California, United States
  • Kivu Trial Site Camperdown, New South Wales, Australia
  • Kivu Trial Site Sydney, New South Wales, Australia
  • Kivu Trial Site Brisbane, Queensland, Australia
View Trial Details
Recruiting

A Study of Raludotatug Deruxtecan With or Without Bevacizumab as First-Line Maintenance Treatment in Non-HRD-Positive Advanced Ovarian Cancer (MK-5909-006, (ENGOT-ov102/GOG-3141/ REJOICE-Ovarian 04)

NCT07776691

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • MedStar Washington Hospital Center ( Site 0026) Washington D.C., District of Columbia, United States
  • Texas Oncology - DFW ( Site 8005) Fort Worth, Texas, United States
  • Sourasky Medical Center ( Site 1403) Tel Aviv, Israel
View Trial Details
Recruiting

A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer

NCT07059845

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • UC San Diego Health - Moores Cancer Center /ID# 277574 La Jolla, California, United States
  • Sansum Clinic - Solvang /ID# 277712 Solvang, California, United States
  • University of Florida College of Medicine /ID# 278348 Gainesville, Florida, United States
  • Orlando Health Cancer Institute Gynecologic Cancer Center - Orlando /ID# 278623 Orlando, Florida, United States
View all 84 locations
View Trial Details
Recruiting

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

NCT06128551

Conditions
Adenocarcinoma, Adnexal Diseases, Appendiceal Neoplasms, +59 more
Locations
  • City of Hope Duarte, California, United States
  • UC IRVINE Health Orange, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • Stanford Cancer Institute Stanford, California, United States
View all 56 locations
View Trial Details
Recruiting

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

NCT07213791

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +39 more
Locations
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Biogenix Molecular, LLC Miami, Florida, United States
  • Moffitt Tampa, Florida, United States
View all 30 locations
View Trial Details
Recruiting

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

NCT07213804

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +23 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • HonorHealth Phoenix, Arizona, United States
  • Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center Burbank, California, United States
  • City of Hope, Duarte Duarte, California, United States
View all 267 locations
View Trial Details

Related conditions